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Abstract
The Na/solute symporter family (SSF, TC No. 2.A.21) contains more than 40 members of pro- and eukaryotic origin.
Besides their sequence similarity, the transporters share the capability to utilize the free energy stored in electrochemical Na
gradients for the accumulation of solutes. As part of catabolic pathways most of the transporters are most probably involved
in the acquisition of nutrients. Some transporters play a role in osmoadaptation. With a high resolution structure still
missing, a combination of genetic, protein chemical and spectroscopic methods has been used to gain new insights into the
structure and molecular mechanism of action of the transport proteins. The studies suggest a common 13-helix motif for all
members of the SSF according to which the N-terminus is located in the periplasm and the C-terminus is directed into the
cytoplasm (except for proteins containing a N- or C-terminal extension). Furthermore, an amino acid substitution analysis of
the Na/proline transporter (PutP) of Escherichia coli, a member of the SSF, has identified regions of particular functional
importance. For example, amino acids of TM II of PutP proved to be critical for high affinity binding of Na and proline. In
addition, it was shown that ligand binding induces widespread conformational alterations in the transport protein. Taken
together, the studies substantiate the common idea that Na/solute symport is the result of a series of ligand-induced
structural changes. ß 2001 Elsevier Science B.V. All rights reserved.
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1. Introduction
Due to the function of (Na/K)-ATPase, Na is
the predominant coupling ion in secondary transport
in animal cells. In prokaryotes, Na is employed as
coupling ion particularly by cells living in extreme
environments like elevated temperatures, high pH
or high external Na concentrations [1,2]. These cells
use primary Na pumps (Na-dependent electron
transport complexes, decarboxylases, ATPase) and
Na/H antiporter(s) to generate Na-electrochemi-
cal gradients [3]. Although in neutrophilic bacteria
solute uptake by secondary transport systems is
mainly coupled to H, accumulation of some solutes
is energized by electrochemical Na gradients. In Es-
cherichia coli, for example, transport of melibiose,
proline, pantothenate and glutamate are coupled to
Na. The necessary Na-electrochemical gradient is
established by the action of Na/H antiporter(s) [4]
(Fig. 1).
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The ever growing number of known transport pro-
teins including Na-dependent cotransporters is clas-
si¢ed in di¡erent families based on their sequence
similarities. There are mixed families of cotransport-
ers that despite their sequence similarity accept either
Na or H or both as coupling ion. Examples are
the glycoside-pentose-hexuronide (GPH) family
(identi¢cation number according to the transporter
classi¢cation (TC) system: No. 2.A.2) and the dicar-
boxylate/amino acid-cation symporter (DAACS)
family (TC No. 2.A.23) [5^8]. Other transporters
fall into distinct families which either contain only
Na or H cotransporters [9]. The Na/solute sym-
porter (SSF) family (or SGLT/PutP family, TC No.
2.A.21) and the Na/neurotransmitter symporter
(NSS) family (TC No. 2.A.22) are examples for fam-
ilies of Na-dependent cotransporters [5,8^10].
Lots of e¡orts are currently made to elucidate the
structure and molecular mechanism(s) of function of
these and other transport proteins. Unfortunately,
structural information at the atomic level is not
available yet for any secondary transporter. Besides
intensive attempts at crystallization, genetic, protein
chemical, spectroscopic and kinetic methods are em-
ployed to obtain new insights into the architecture
and way(s) of energy transduction of the transport-
ers.
This article summarizes recent ¢ndings on the
structure and function of members of the SSF, there-
by focusing on the prokaryotic part of the family.
The results are discussed with respect to achieve-
ments and models for other secondary transporters.
2. Prokaryotic members of the SSF
The SSF currently comprises more than 40 similar
proteins from archaea, bacteria, yeast, insects, and
mammals [10]. The proteins catalyze the following
general transport process:
nNaout  soluteout2nNain  solutein
Under physiological conditions usually an in-
wardly directed electrochemical Na gradient
(v ~WNa = RT ln([Naout]/[Na

in])3Fv8, where F is
the Faraday constant, v8 is the membrane electrical
potential di¡erence, R is the gas constant and T is
the absolute temperature) is used to drive the uphill
transport of a solute [11,12]. Among the eukaryotic
members of the SSF are the human transporters for
glucose (SGLT1), nucleosides (SNST1), myo-inositol
(SMIT1) and iodide (NIS) [10]. The known prokary-
otic members of the SSF use v ~WNa to speci¢cally
accumulate proline, galactose (glucose), pantothenate
or phenyl acetate in cells (Table 1). PanF, the Na/
pantothenate transporter of E. coli and other pro-
karyotes, scavenges extracellular pantothenate for
coenzyme A biosynthesis in the cells [13]. Most of
the other characterized transporters are part of ca-
tabolic pathways and are used for the acquisition of
the corresponding solute as carbon source [14^17].
For example, the putP gene encoding the Na/pro-
line transporter of E. coli and Salmonella typhimuri-
um is part of the put operon which also encodes a
proline dehydrogenase (product of putA gene) allow-
ing the use of proline as a source of nitrogen and/or
carbon [14,18] (Fig. 1). Expression of the transporter
genes is usually induced by the speci¢c solute or
some product thereof.
In this context, OpuE, a Na/proline transporter
of Bacillus subtilis, is an exception since it serves
osmoprotective purposes and is apparently not in-
volved in a catabolic pathway [19,20]. While the ac-
tivity of the catabolic Na/proline transporter PutP
Fig. 1. Role of PutP in E. coli. PutP catalyzes the Na coupled
uptake of proline with a stoichiometry of 1:1 [57^60]. The elec-
trochemical Na gradient required to energize proline transport
is generated by the action of Na/H antiporter(s). Subsequent
to the uptake process proline is oxidized via pyrroline 5-carboxyl-
ate to L-glutamate [14]. The two oxidation steps are catalyzed
by a single protein, the product of the putA gene, which also
acts as a repressor of put operon transcription in the absence of
L-proline [111].
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of E. coli and S. typhimurium is actually reduced
when the cells are grown under high osmolarity con-
ditions, OpuE activity is strongly enhanced in hyper-
tonic medium, thereby highlighting the distinct phys-
iological functions of the PutP and OpuE proteins
[20,21]. The osmoregulated proline transport activity
of OpuE is entirely dependent on de novo protein
synthesis and is controlled at the transcriptional level
[19,20]. Osmosensory properties as observed for the
osmoprotectant uptake systems ProP of E. coli or
BetP of Corynebacterium glutamicum could not be
detected for OpuE [20,22,23]. The genome sequenc-
ing project of B. subtilis revealed that the bacterium
probably contains a second proline transporter,
YcgO, which is highly similar to OpuE and probably
involved in proline catabolism [24] (E. Bremer, per-
sonal communication). Thus, two closely related pro-
teins are obviously used for di¡erent physiological
functions by putting their structural genes under
the control of di¡erent regulatory schemes [20]. Be-
side OpuE of B. subtilis, PutP-1 of the hyperthermo-
philic archaeon Pyrococcus abyssi (28% identical
amino acids with OpuE of B. subtilis) is postulated
to be osmoregulated [25].
Interestingly, some of the prokaryotic members of
the SSF may represent new targets for the develop-
ment of new drugs against pathogens. Thus, the high
a⁄nity Na/proline transporter PutP of Staphylococ-
cus aureus contributes to in vivo survival of this caus-
ative organism of a wide variety of human infections
Table 1
Prokaryotic members of the SSF (TC No. 2.A.21)
Transported solute Organisms Gene name Accession No. Reference
proline E. coli putP P07117 [21,37]
S. typhimurium putP P10502 [59,97]
Pseudomonas putida putP Q9R9T6 [16]
Pseudomonas £uorescens putP Q57023 [98]
K. pneumoniae putP (?)a P23723 [112]
Helicobacter pylori putP (?) O24896 [99]
Campylobacter jejuni putP (?) Q9PMG1 [113]
Neisseria meningitidis putP (?) Q9JR87 (preliminary) [114]
Vibrio cholerae putP (?) ^b [115]
Haemophilus in£uenzae putP (?) P45174 [100]
Rickettsia typhi putP (?) Q53255 [96]
S. aureus putP O30986 [26,101]
C. glutamicum putP O32355 [15]
B. subtilis opuE O06493 [20,24]
ycgO (?) P94392 [20,24]
Chlamydia pneumoniae putP (?) Q9Z865 [102]
Archaeoglobus fulgidus putP-1 (?) O30220 [103]
putP-2 (?) O29293
putP-3 (?) O29046
Pyrococcus horikoshii putP (?) O59086 [104]
Methanobacterium thermoautotrophicum putP (?) O27884 [105]
pantothenate E. coli panF P16256 [13]
H. in£uenzae panF (?) P44963 [100]
Rickettsia prowazekii panF (?) Q9ZCY0 [106]
Borrelia burgdorferi panF (?) O51754 [107]
A. fulgidus panF-1 (?) O29193 [103]
panF-2 (?) O29063
panF-3 (?) O30002
phenyl acetate P. putida ppa O50471 [17,108]
galactose (glucose) Vibrio parahaemolyticus vSGLT P96169 [109]
? Synechocystis sp. Na/solute symporter (?) P74252 [110]
aThe functional assignment is based on sequence similarities.
bV. cholerae El Tor N16961 gene locus VCA1071 [116].
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[26]. It could be shown that insertional inactivation
of the putP gene of S. aureus leads to signi¢cantly
reduced virulence in experimental endocarditis [27].
3. Transporter structure
Understanding the molecular mechanism of func-
tion of the transport proteins requires detailed struc-
tural information. Indeed, X-ray crystallography has
yielded major advances in the understanding of
channel-type proteins and both light- and electron
£ow-driven ion pumps [28^31]. However, as stated
above a major problem in the ¢eld of secondary
transport is the di⁄culty inherent in obtaining struc-
tural information on the proteins involved at a rele-
vant level of resolution. The ¢rst direct glimpse into
the structure of a secondary transporter was pro-
vided by two-dimensional crystallization and electron
cryo-microscopy of the Na/H antiporter NhaA of
E. coli [32]. Based on these studies a three-dimen-
sional map of NhaA was produced that reveals 12
tilted, bilayer spanning helices. A roughly linear ar-
rangement of six helices is adjacent to a compact
bundle of six helices, with the density for one helix
in the bundle not continuous through the membrane
[33]. Besides intensive trials to crystallize the trans-
porters, cysteine cross-linking studies and site-di-
rected labeling analyses in combination with spectro-
scopic methods are used to obtain information on
helix packing in secondary transport proteins like
the lactose permease of E. coli [34^36]. Information
on tertiary interactions within SSF proteins is not
available yet. However, knowledge on the secondary
structure of the polypeptide chains and their topo-
logical arrangement in the membrane has signi¢-
cantly improved in the last couple of years.
The average hydropathy plot for SSF proteins pre-
dicts 11^15 transmembrane domains (TMs) in K-hel-
ical conformation [9]. Most experimental evidence on
the topological arrangement comes from studies on
the Na/proline transporter PutP of E. coli (Fig. 2).
PutP has originally been proposed to consist of a
short hydrophilic N-terminal region, 12 transmem-
brane domains in K-helical conformation that tra-
verse the membrane in zigzag fashion connected by
hydrophilic loops, and a hydrophilic C-terminal tail
[37]. According to the model 60% of the 502 amino
acids of PutP are found in hydrophobic domains
with a mean length of 24 amino acids. Circular di-
chroic measurements of puri¢ed and reconstituted
PutP indicate that the protein is about 63% K-helical
in conformation thereby approaching the predicted
value (T. Pirch, J. Greie and H. Jung, unpublished).
The 12-helix model of PutP has further been tested
by applying a gene fusion approach, immunological
Fig. 2. Secondary structure model of PutP of E. coli (according to [39,42]). Putative transmembrane domains are represented as rec-
tangles and numbered with Roman numerals ; loops are numbered with Arabic numerals starting from the N-terminus. Amino acid
residues shown to be critical for Na and/or proline binding are indicated by open letters. Residues proposed to participate in confor-
mational alterations are shown as bold letters.
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and site-directed labeling techniques. Analysis of a
series of putP-phoA and putP-lacZ fusions yields a
reciprocal activity pattern of the reporter proteins
alkaline phosphatase (PhoA) and L-galactosidase
(LacZ) that is in agreement with the topology of
TMs III^XII of the 12-helix model [38,39]. However,
di¡ering from the topology prediction, the fusion
analysis suggests a shift of the boarders of putative
TM II by eight amino acids towards the C-terminus,
thereby creating a large preceding periplasmic loop.
Placement of PutP-PhoA junction points into this
loop does not yield conclusive results. Therefore, a
cysteine accessibility analysis was performed to de-
termine the topology of the N-terminal part of PutP.
Surprisingly, cysteine residues placed close to the
N-terminus of PutP (Ile3CCys, Thr5CCys) are
highly accessible to membrane permeant and imper-
meant thiol reagents from the periplasmic space. In
contrast, cysteine at the C-terminus is accessible only
from the cytosolic side of the membrane as indicated
also by immunological studies [39,40]. These results
contradict the 12-helix motif and indicate a periplas-
mic location of the N-terminus while the C-terminus
faces the cytoplasm. In addition, the accessibility pat-
tern of cysteine residues placed into the periplasmic
loop (pL) preceding TM II (pL 2) suggests the for-
mation of an additional TM formed by amino acids
of this loop (Fig. 2). The results are in good agree-
ment with site-speci¢c proteolysis studies performed
with unidirectionally reconstituted PutP [39,41].
Finally, site-directed spin labeling and electron
paramagnetic resonance (EPR) spectroscopy were
used to test the altered structural arrangement of
PutP [42]. Information on spin label topography
was obtained by analyzing the residual mobility of
site-speci¢cally attached nitroxide side chains and
determination of collision frequencies of the nitro-
xide with non-polar oxygen and polar CROX. The
method is well established with a variety of mem-
brane proteins [43^47]. For PutP, the measurements
indicate that TM II is composed of amino acids
Ser41 to Gly66 while TM III (TM II in the 12-helix
model) comprises residues Ser76 to Gly95 [42] (Fig.
2).
Based on these studies a new secondary structure
model of PutP was proposed according to which the
protein consists of 13 TMs with the N-terminus on
the periplasmic side of the membrane and the C-ter-
minus facing the cytoplasm [39,42] (Fig. 2). An addi-
tional TM is formed by amino acid residues of for-
mer pL 2 placing the functionally important residues
Asp55 and Ser57 (see below) from a periplasmic loop
region into a TM (now TM II). The new secondary
structure model of PutP is in agreement with the
recently proposed topological arrangement of TMs
I to XIII of SGLT1 which is based on a N-glycosyl-
ation study [48]. The 13-helix feature was also veri-
¢ed for the mammalian Na/I3 transporter [49].
Taken together, the results support the idea of a
common topological motif for members of the SSF
according to which, for example, the bacterial trans-
porters for proline (PutP) and pantothenate (PanF)
and the mammalian Na/I3 transporter are com-
posed of 13 TMs. Transporters with a C-terminal
extension (for example, the human SGLT1 and the
Na/myo-inositol transporter (SMIT1)) are proposed
to have an additional 14th TM [10,48].
The periplasmic location of the N-terminus is an
unexpected feature of the 13-helix motif implying
that, beginning from the N-terminus, the transporter
starts with a stop transfer sequence and not a signal
anchor sequence. The mechanism of insertion of the
polypeptide chain is not known. For PutP of E. coli
it can be stated that despite the N-terminus itself the
stretch of the ¢rst 27 amino acids of PutP is highly
hydrophobic and does not contain any charged res-
idues. The N-terminal primary structures of PutP
and PanF of other bacteria and of vSGLT are sim-
ilar. So, it can be speculated that the energy required
to translocate the short N-terminal tail of PutP and
other members of the SSF across the membrane is
gained from the transition of hydrophobic TM I
from the aqueous phase into the apolar phase of
the bilayer. Indeed, analysis of hybrid proteins gen-
erated from E. coli leader peptidase and the phage
Pf3 coat protein reveals that short tails which do not
contain positively charged residues are e⁄ciently
translocated independent of the Sec machinery [50].
The cytoplasmic loop that follows the inwardly di-
rected TM I according to the 13-helix model contains
three positively and two negatively charged residues.
Altogether, the new topological arrangement ¢ts very
well the positive inside rule [51].
As far as investigated, the 13-helix motif appears
to be a special feature of the SSF. The 12-helix ar-
rangement is most common among secondary trans-
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porters including Na-dependent systems [5]. The
melibiose permease of E. coli, a member of GPH
family (TC No. 2.A.2), is a well studied example
for a 12-helix transporter able to catalyze Na/solute
cotransport [52,53]. However, di¡erent TM numbers
are not exceptional [5,7]. For example, a speci¢c
topological model in which seven K-helical TMs are
followed by a reentrant loop-pore structure followed
by one ¢nal TM is proposed for members of the
DAACS family (TC No. 2.A.23) [7,54], and an 11
TM topology has been experimentally documented
for the Klebsiella pneumoniae Na/citrate transporter
CitS, a member of the cation/citrate symporter
(CCS) family (TC No. 2.A.24) [55,56].
4. Functional properties of PutP
PutP of E. coli is the best characterized prokary-
otic member of the SSF, and its main functional
properties are therefore brie£y summarized here.
The gene product is an integral protein of the cyto-
plasmic membrane and catalyzes the coupled trans-
location of proline and Na with a stoichiometry of
1:1 [57^60]. PutP is highly speci¢c for proline and
has to be discriminated from ProP and ProU which
transport proline but also glycine betaine and other
betaines in response to osmotic stress [61^65]. ProP is
a secondary, H-linked transport system and belongs
to the major facilitator superfamily (TC No. 2.A.1)
[66]. The isolated protein has recently been shown to
act as an osmosensor and an osmoregulator [22].
ProU is a binding protein-dependent ABC transport-
er which preferentially transports glycine betaine and
shows a relatively low a⁄nity and uptake rate for
proline compared to glycine betaine [61].
The putP gene was cloned and sequenced
[37,67,68], and the gene product has been solubilized
from the cytoplasmic membrane, puri¢ed, reconsti-
tuted into proteoliposomes, and shown to be solely
responsible for Na/proline transport [41,69,70]. Li
can substitute for Na ; however, despite earlier as-
sumptions H driven proline uptake by PutP could
not be demonstrated [57,58]. In the cell, Na/proline
symport is thermodynamically coupled to Na/H
antiport, and in this way PutP is part of the Na
circuit of E. coli (Fig. 1).
The Km values for Na and proline uptake by
PutP were determined with 30 and 2 WM, respectively
[18]. Kinetic analyses of Na/solute symport cata-
lyzed by di¡erent members of the SSF including
PutP suggest that transport occurs according to an
ordered binding mechanism [71^74] (Fig. 3). In this
scheme, Na binds to the empty transporter ¢rst
thereby inducing a conformational alteration which
increases the a⁄nity of the transporter for the solute.
The formation of the ternary complex induces anoth-
er structural change that exposes Na and solute to
the other site of the membrane. Solute and Na are
released and the empty transporter reorientates in the
membrane allowing the cycle to start again.
5. Sites important for Na+ and/or solute binding
Labeling experiments, random and site-directed
mutagenesis have been employed to identify func-
tionally important sites in members of the SSF.
Most comprehensive studies are available for PutP
of E. coli and S. typhimurium.
To identify residues involved in cation binding,
putP mutants that confer resistance to Li during
growth on proline were isolated. The location of
each mutation was determined by deletion mapping:
the mutations cluster in two small deletion intervals
at the 5P and 3P termini of the putP gene [75]. Recent
site-directed mutagenesis studies have established
that amino acids of TM II of PutP (Fig. 2) are of
particular functional importance, thereby strongly
Fig. 3. Ordered binding model of Na/solute symport (based
on [71^74]; see text for details).
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supporting the idea that the N-terminal part of the
transporter is responsible for Na binding. Thus, out
of ¢ve acidic residues in the N-terminal domain an-
alyzed, the carboxylate of Asp55 (TM II) proved to
be essential for transport while Asp33, Asp34 (both
cytoplasmic loop (cL) 2), and Glu75 (pL 3) were
dispensable for function [76]. Signi¢cant albeit highly
reduced activity was detected with Glu in place of
Asp55 (PutP-D55E). Kinetic analysis of active trans-
port catalyzed by the latter PutP derivative revealed
a 50-fold decrease of the apparent a⁄nity of the
protein for sodium ions compared to the wild-type
transporter. On the other hand, only a relatively
small alteration of the apparent a⁄nity for proline
was observed [76]. Furthermore, Na binding could
not been detected for PutP missing a carboxylate at
position 55. These results suggest that Asp55 is lo-
cated at or close to a binding site of the coupling ion.
In addition, individual replacement of Met56,
Ser57 or Gly58 following Asp55 in TM II led to
signi¢cantly altered transport kinetics. Thus, substi-
tution of Ser57 with Ala, Cys, Gly, or Thr increased
the apparent Km values for Na (and Li) AND
proline by up to two orders of magnitude with little
in£uence on Vmax values [77]. Similarly, Cys in place
of Met56 or Gly58 caused an increase in the appar-
ent Km values for Na AND proline although the
extent of the e¡ect was less dramatic as in case of
Ser57 (M. Nietschke, S. Landmeier, M. Quick and
H. Jung, unpublished). These results support the idea
that the sites of Na and proline binding are over-
lapping. The latter idea is in agreement with ¢ndings
on melibiose permease of E. coli implicating Asp55
of the sugar transporter in the binding of both ion
and substrate [78]. However, in the case of PutP, Cys
accessibility analyses challenge the idea of Ser57 and
Gly58 being part of a Na binding site. Thus, the
reaction rate of a Cys placed at the positions of
Ser57 and Gly58 of PutP with sulfhydryl-speci¢c re-
agents was not blocked by Na as expected for res-
idues being directly involved in binding of the ligand
but signi¢cantly stimulated by the ion (T. Pirch and
H. Jung, unpublished). Obviously, ion binding to a
site di¡erent from Ser57 and Gly58 induced a con-
formational alteration that increased the accessibility
of the amino acids at positions 57 and 58. These
observations make a direct involvement of Ser57
and Gly58 in Na binding unlikely. The accessibility
of Cys at the position of Met56 was not signi¢cantly
in£uenced by Na.
In the Propionigenium modestum F1F0 ATP syn-
thase Gln32, Glu65 and Ser66 of subunit c were
shown to be Na binding ligands [79]. In view of
these ¢ndings, Ser54 which precedes Asp55 in TM
II of PutP was another candidate for a Na ligand-
ing group of the transporter. Replacement of Ser54
with Cys yielded an about 8-fold decrease of the ap-
parent a⁄nity of PutP for Na with no signi¢cant
e¡ect on the proline a⁄nity. Na did not signi¢-
cantly a¡ect the Cys accessibility at position 54 sim-
ilar as observed for Cys in place of Met56 [39] (T.
Pirch, M. Nietschke and H. Jung, unpublished).
Clearly, further substitution analyses are necessary
to clarify the role of Ser54 and Met56 in Na bind-
ing.
Arg40 (cytoplasmic end of TM II) of PutP which
is conserved within the SSF was also subjected to
amino acid substitution analysis [80]. Removal of
the positive charge at position 40 (PutP-R40C, Q,
E) led to a dramatic decrease of the turnover num-
bers for Na-coupled proline uptake (1^10% of
PutP-wild-type). The reduced transport rates were
accompanied by decreased apparent a⁄nities of the
transporter for Na and Li while the apparent af-
¢nity for proline was only slightly altered. Further-
more, single Cys PutP-R40C reacted with N-ethyl-
maleimide (NEM), and this reaction was partially
inhibited by proline and more e⁄ciently by sodium
ions. Remarkably, NEM modi¢cation of Cys40 in-
hibited Na-driven proline uptake almost completely
while facilitated in£ux of proline into de-energized
cells was stimulated by this reaction indicating an
at least partially uncoupled phenotype under these
conditions [80]. These results suggest that Arg40 is
located close to the site of ion binding and is impor-
tant for the coupling of ion and proline transport.
Besides the discussed role of amino acids of TM II
in Na liganding, some residues in this segment
proved to be important for proline binding. As al-
ready described above, even conservative replace-
ments for Ser57 and Gly58 caused a dramatic de-
crease of the apparent a⁄nity of PutP for proline.
In addition, substitution of Ser57 reduced the sensi-
tivity of E. coli cells to the toxic proline analogues
L-acetidine-2-carboxylate (AZT) and 3,4-dehydro-
D,L-proline (DHP) [77]. Remarkably, while Na in-
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creased the accessibility of Cys in place of Ser57 or
Gly58, proline inhibited the reaction of the residue
with sulfhydryl-speci¢c reagents at both positions,
thereby reversing the Na e¡ect almost completely
(T. Pirch and H. Jung, unpublished). Taken together
the ¢ndings propose a location of Ser57 and Gly58 at
or close to the proline binding site of PutP. Clearly,
it cannot be excluded that protection of Cys at posi-
tions 57 and 58 is achieved by a proline-induced
conformational alteration and not by direct steric
hindering. In any case, it is very likely that Ser57
and Gly58 participate in the transmission of a
Na-induced conformational alteration leading to
high a⁄nity proline binding to a site that is at least
close to these positions in the tertiary structure of the
transporter. The observations con¢rm the functional
importance of TM II described above.
The proposed participation of TM II in proline
binding apparently contradicts results obtained with
SGLT1, suggesting that the C-terminal domain is
responsible for substrate binding and translocation.
Thus, analysis of chimeras consisting of sequences of
the high a⁄nity transporter SGLT1 and the low af-
¢nity transporter SGLT2 suggest that recognition/
transport of organic substrate is mediated by inter-
actions distal to amino acid 380 [81]. In addition it
was shown that a SGLT1 fragment comprising only
the last ¢ve TMs of the transporter is able to catalyze
Na-independent facilitated di¡usion of sugar
[82,83]. However, it has to be taken into account
that the sugar a⁄nity of the C-terminal fragments
of SGLT1 tested was highly reduced, thereby leaving
the possibility that amino acid residues of the N-ter-
minal part of the protein contribute to high a⁄nity
binding of the organic substrate.
The idea that multiple regions of PutP contribute
to solute binding is supported by the analysis of putP
mutants with an altered speci¢city for proline, AZT
and DHP [84]. Deletion mapping of the mutants re-
vealed that the mutations cluster in three distinct
regions of the putP gene. One set of mutants was
mapped at the distal end of the putP gene, thereby
implicating the C-terminal region of PutP in sub-
strate recognition.
Besides amino acid residues of TM II, Asp187 (cL
6) and Arg257 (cL 8) of PutP were shown to be of
functional importance [85,86] (Fig. 2). The residues
are conserved within members of the SSF. Substitu-
tion of Asp187 yielded highly reduced transport rates
which in case of PutP-D187C could be stimulated by
acetylation or amidoacetylation of the engineered
Cys [85]. In contrast to the wild-type, proline binding
to PutP-D187C was apparently independent from
Na. In addition, reaction of PutP containing a sin-
gle Cys at position 187 with NEM was inhibited by
Na but not by Li or proline. The results indicate
that electrostatic interactions of the amino acid side
chain at position 187 in PutP with other parts of the
transporter and/or the coupling ion are crucial for
active proline transport. It was suggested that
Asp187 is located close to the pathway of the cou-
pling ion through the membrane and may be in-
volved in the release of Na on the cytoplasmic
side of the membrane [85]. A reduced Na depen-
dence of proline binding was also observed upon
replacement of Arg257 with Cys [86]. The authors
speculate that removal of the positive charge leads
to an enhanced a⁄nity of PutP for Na. However,
the e¡ect of the substitution of Arg257 on proline
uptake was much less dramatic than in case of
Asp187.
Originally, the native Cys residues at positions 281
(TM VIII) and 344 (TM IX) of PutP were identi¢ed
as substrate-protectable residues and suggested to re-
side close to the binding site for the coupling ion
and/or proline [87,88]. However, replacement of
these Cys residues neither a¡ected proline uptake
nor altered the sensitivity of E. coli cells to the
toxic proline analogue AZT signi¢cantly, thereby in-
dicating that the two Cys residues may not be di-
rectly involved in binding [87,88]. Finally, a fully
functional PutP molecule devoid of all ¢ve native
Cys residues was constructed, demonstrating that
Cys residues are not important for the function of
PutP similar as shown for other secondary transport-
ers [39,89,90].
Finally, alignment of amino acid sequences of
members of the SSF led to the proposal of a sodium
binding (SOB) motif which has the following consen-
sus sequence: GX35ÿ37AX3(EQ)LX3GR [9]. In PutP
of E. coli the conserved amino acids are Gly328 (TM
IX), Ala366, Glu370 (cL 10), Leu371, Gly375 and
Arg376 (TM X). However, a substitution analysis
of Arg376 reveals that the residue does not reside
at the Na binding site, thereby suggesting that the
proposed motif is not essential for function [91].
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6. Ligand-induced conformational alterations
The ordered binding model implies that Na/sol-
ute transport is the result of a series of ligand-in-
duced conformational changes in the protein. To ex-
plore the nature of these changes protein labeling
and spectroscopic methods were used. For PutP,
these changes were analyzed by site-directed spin la-
beling and EPR spectroscopy [42]. The study utilized
the sensitivity of nitroxide mobility to tertiary inter-
actions as means of detecting conformational move-
ments in PutP. Analysis of EPR lineshapes revealed
ligand-induced mobility changes of nitroxide at-
tached to positions 37 (cL 2) and 45 (TM II) of
the transporter. In the case of single Cys PutP-
L37C, binding of Na and/or proline to the trans-
porter led to a mobilization of the spin label while
the nitroxide at position 45 became less mobile upon
addition of proline, and Na alone had no e¡ect.
From these ¢ndings it was concluded that proline
binding induces a conformational alteration of
PutP that involves at least parts of TM II and the
preceding cytoplasmic loop. Na could only be
shown to a¡ect the structure of cL 2 [42].
The EPR studies were con¢rmed and extended by
Cys accessibility studies in the presence and absence
of ligands. Thus, Na was shown to increase the
accessibility of Cys placed at the position of Ser57,
Gly58 (TM II), Ser71 or Glu75 (pL 3). In contrast to
Ser57 and Gly58 (see above), proline did not a¡ect
the accessibility of Cys at positions 71 and 75. Fur-
thermore, proline inhibited the reaction of sulfhy-
dryl-speci¢c reagents with Cys at the positions of
Phe45, Val46, Thr47, Leu49, Ser50 and Ala51 (all
TM II) (T. Pirch, M. Langkamp and H. Jung, un-
published). The substrate protected sites are not clus-
tered on one phase of the putative K-helix but dis-
tributed around it. Furthermore, substitution of
these residues had little or no e¡ect on the proline
uptake kinetics, suggesting that in these cases protec-
tion was achieved by proline-induced conformational
alterations and not by direct steric hindering as dis-
cussed for Ser57 and Gly58. Similarly, proline re-
duced the accessibility of Cys at the positions of
Ser223 (pL 7), Pro252 (TM VII), Arg257 (cL8) and
Cys344 (TM IX) ([38,39,86^88]; T. Pirch and H.
Jung, unpublished). Na alone had no signi¢cant
e¡ect. Replacement of these amino acids had little
Fig. 4. Model of Na/proline symport by PutP of E. coli. Transport is proposed to proceed according to the following consecutive
steps. (1) Binding of Na to the empty transporter at or close to Asp55 in TM II of PutP. Binding of the ion induces a conforma-
tional change that involves at least TM II and the adjoining loops. (2) High a⁄nity proline binding to the transporter at or close to
Ser57 and Gly58 of TM II. (3) Conformational alterations of the ternary complex involving at least TM II, VII, IX and adjoining
loops expose the ligand binding sites to the other site of the membrane. (4) Release of proline and (5) Na whereby Asp187 in cL 6
plays a critical role. (6) Conformational alteration of the empty transporter to allow the cycle to start again (see text for further infor-
mation).
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or no e¡ect on the apparent proline a⁄nity of the
transporter despite reduced turnover numbers. In ad-
dition, analysis of 2-(4P-maleimidylanilino)naphtha-
lene-6-sulfonic acid (MIANS)-labeled PutP-S223C
revealed signi¢cant changes in the £uorescence emis-
sion spectrum upon addition of proline if Na was
present. The studies suggest that at least parts of TM
VII and adjoining loops are involved in structural
alterations probably occurring after formation of
the ternary complex between transporter, Na and
proline (Fig. 4).
For SGLT1 it was shown by similar labeling ex-
periments that the reaction of Cys in place of Gln457
with a sulfhydryl-speci¢c probe requires Na, and
the reaction is blocked by external sugar [92]. The
study implicates Gln457 in conformational altera-
tions that are responsible for the coupling of Na
and sugar transport.
The precise nature of the structural alterations in
the transport proteins is still unclear. It can be specu-
lated that binding of Na and solute induces changes
in helix tilt or helix rotation similar as it has been
proposed for ligand-induced helix movements in the
lactose permease of E. coli [93^95].
7. Conclusions
The SSF is a large family of Na/solute cotrans-
porters of pro- and eukaryotic origin. Most of the
transporters are most probably required for the ac-
quisition of nutrients. Analyses of secondary struc-
ture and membrane topology propose a 13-helix ar-
rangement as a common structural motif for all
members of the SSF. Kinetic analyses in combina-
tion with amino acid substitution, site-directed label-
ing and spectroscopic studies provide ¢rst glimpses
of the sites of ligand binding. Furthermore, the re-
sults indicate that the Na and solute binding sites
communicate with each other via conformational al-
terations. For Na/proline symport by PutP of E. coli
the studies support the following model (Fig. 4). In a
¢rst step Na binds to the empty transporter at or
close to Asp55 in TM II of PutP. Binding of the ion
induces a conformational change that involves at
least TM II and the adjoining loops. As part of this
change Ser57 and Gly58 move from a buried into a
highly accessible position (step 1). The structural re-
arrangement results in high a⁄nity proline binding
to the transporter whereby Ser57 and Gly58 either
participate directly in proline binding or are located
close to the binding site in the tertiary structure of
the protein (step 2). The formed ternary complex
undergoes another structural alteration that exposes
the ligand binding sites to the other site of the mem-
brane. This rearrangement involves at least TM II,
VII, IX and adjoining loops (step 3). Subsequently,
proline and Na are released whereby Asp187 in cL
6 plays a critical role (steps 4 and 5). In the last step
of the cycle, the empty transporter reorientates in the
membrane to allow the cycle to start again (step 6).
Clearly, additional analyses are required to obtain a
complete picture of the sites of Na and proline
binding and of the residues forming the translocation
pathway. Furthermore, since conformational changes
are apparently essential for the transport process
more information on the precise nature and the ex-
tent of the changes must be obtained, i.e., by double
spin labeling techniques or FTIR spectroscopy. Fi-
nally, notwithstanding the power of molecular bio-
logical, protein chemical and biophysical techniques
it is obvious that without high resolution structural
information, interpretation of the results of part of
the manipulations, particularly those related to the
molecular mechanism of energy coupling, will remain
speculative. Clearly, new insights into the structure
and function of prokaryotic members of the SSF will
contribute to a better understanding of the basic bio-
chemical mechanism of energy transduction. More-
over, since some of the transporters proved to be
important for bacterial virulence, the studies may
also lead to new strategies for the development of
drugs against pathogens.
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